Adolore BioTherapeutics, Inc., (”Adolore” or the “Company”), a biotechnology company developing transformational opioid-free intracellularly-delivered treatments for chronic pain, today announced that ...
While our inflection developed a couple of quarters later than expected, we believe the important measure is not the timing, but rather the size of the vector we are creating in comparison to our ...
DELRAY BEACH, FL / ACCESSWIRE / September 24, 2024 / Adolore BioTherapeutics, Inc., ("Adolore" or the "Company"), a biotechnology company developing transformational opioid-free intracellularly-delive ...